Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils
AuthorsRomana Vantur; Marusa Rihar; Ana Koren; Matija Rijavec; Peter Kopac; Urska Bidovec-Stojkovic; Renato Erzen; Peter Korosec
Affiliations1. University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; 2. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium
AuthorsCancan Qi; Judith M. Vonk; Diana A. van der Plaat; Maartje A. E. Nieuwenhuis; F. Nicole Dijk; Dylan Aïssi; Valérie Siroux; H. Marike Boezen; Cheng-jian Xu; Gerard H. Koppelman
Affiliations1. Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2. GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 4. University Grenoble Alpes, Inserm, CNRS, Team of environmental epidemiology applied to Reproduction and Respiratory health, IAB (Institute for Advanced Biosciences), Grenoble, France; 5. Research Group of Bioinformatics and Computational Genomics, CiiM, Centre for individualized infection medicine, A Joint Venture Between Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 6. Department of Gastroenterology, Hepatology and Endocrinology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
A novel ELISA method to determine human MrgX2 in chronic urticaria
AuthorsYuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong He
Affiliations1. College of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
AuthorsA. Bédard; X. Basagaña; J. M. Anto; J. Garcia-Aymerich; P. Devillier; S. Arnavielhe; A. Bedbrook; G. L. Onorato; W. Czarlewski; R. Murray; R. Almeida; J. A. Fonseca; J. Correia da Sousa; E. Costa; M. Morais-Almeida; A. Todo-Bom; L. Cecchi; G. De Feo; M. Illario; E. Menditto; R. Monti; C. Stellato; M. T. Ventura; I. Annesi-Maesano; I. Bosse; J. F. Fontaine; N. Pham-Thi; M. Thibaudon; P. Schmid-Grendelmeier; F. Spertini; N. H. Chavannes; W. J. Fokkens; S. Reitsma; R. Dubakiene; R. Emuzyte; V. Kvedariene; A. Valiulis; P. Kuna; B. Samolinski; L. Klimek; R. Mösges; O. Pfaar; S. Shamai; R. E. Roller-Wirnsberger; P. V. Tomazic; D. Ryan; A. Sheikh; T. Haahtela; S. Toppila-Salmi; E. Valovirta; V. Cardona; J. Mullol; A. Valero; M. Makris; N. G. Papadopoulos; E. P. Prokopakis; F. Psarros; C. Bachert; P. W. Hellings; B. Pugin; C. Bindslev-Jensen; E. Eller; I. Kull; E. Melén; M. Wickman; G. De Vries; M. van Eerd; I. Agache; I. J. Ansotegui; S. Bosnic-Anticevich; A. A. Cruz; T. Casale; J. C. Ivancevich; D. E. Larenas-Linnemann; M. Sofiev; D. Wallace; S. Waserman; A. Yorgancioglu; D. Laune; J. Bousquet
Affiliations1. ISGlobal, Barcelona, Spain; 2. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 3. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 4. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5. UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; 6. KYomed INNOV, Montpellier, France; 7. CHU de Montpellier, Montpellier, France; 8. Medical Consulting Czarlewski, Levallois, France; 9. Research fellow, OPC, and Director, Cambridge, UK; 10. Medscript, Paraparaumu, New Zealand; 11. Faculdade de Medicina da Universidade do Porto, Lda Porto, Portugal; 12. MEDIDA, Lda, Porto, Portugal; 13. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; 14. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal; 15. Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 16. UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 17. Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal; 18. Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 19. SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; 20. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 21. Division for Health Innovation, Campania Region, Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; 22. CIRFF, Federico II University, Naples, Italy; 23. Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino, Mauriziano Hospital, Turin, Italy; 24. Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; 25. Medical School Saint Antoine, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Paris, France; 26. Allergist La Rochelle, La Rochelle, France; 27. Allergist, Reims, France; 28. Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France; 29. RNSA (Réseau National de Surveillance Aérobiologique), Brussieu, France; 30. Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 31. Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 32. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands; 33. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands; 34. Clinic of Chest Diseases, Immunology and Allergology, Medical Faculty, Vilnius University, Vilnius, Lithuania; 35. Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 36. Department of Pathology, Faculty of Medicine and Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania; 37. Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; 38. European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium; 39. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 40. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; 41. Center for Rhinology and Allergology, Wiesbaden, Germany; 42. Medical Faculty, CRI-Clinical Research International-Ltd, Institute of Medical Statistics, and Computational Biology, University of Cologne, Hamburg, Germany; 43. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany; 44. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 45. Department of ENT, Medical University of Graz, Graz, Austria; 46. Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK; 47. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 48. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 49. Department of Lung Diseases and Clinical Immunology, University of Turku, Terveystalo Allergy Clinic, Turku, Finland; 50. Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, ARADyAL Research Network, Barcelona, Spain; 51. Rhinology Unit, & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; 52. Pneumology and Allergy Department CIBERES and Clinical, & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain; 53. Allergy Unit “D Kalogeromitros”, 2nd Dpt of Dermatology and Venereology, National & Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece; 54. Division of Infection, & Respiratory Medicine, Royal Manchester Children’s Hospital Immunity, University of Manchester, Manchester, UK; 55. Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P&A Kyriakou,” University of Athens, Athens, Greece; 56. Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece; 57. Allergy Department, Athens Naval Hospital, Athens, Greece; 58. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium; 59. Sun Yat-sen University, International Airway Research Center, Guangzou, China; 60. Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; 61. Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden; 62. Academic Medical Center, Univ of Amsterdam, Dept of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, The Netherlands; 63. European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 64. Odense University Hospital, Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; 65. Thermofisher Scientific, Uppsala, Sweden; 66. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach´s Children and Youth Hospital, Södersjukhuset, Sweden; 67. Sachs’ Children and Youth Hospital, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 68. Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 69. Peercode BV, Geldermalsen, The Netherlands; 70. Transylvania University Brasov, Brasov, Romania; 71. Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; 72. Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, Australia; 73. Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; 74. WHO GARD Planning Group, Salvador, Brazil; 75. Division of Allergy/Immunology, University of South Florida, Tampa, USA; 76. Clinica Santa Isabel, Servicio de Alergia e Immunologia, Buenos Aires, Argentina; 77. Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; 78. Finnish Meteorological Institute (FMI), Helsinki, Finland; 79. Nova Southeastern University, Fort Lauderdale, USA; 80. Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Canada; 81. Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; 82. University Hospital, Montpellier, France; 83. INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; 84. Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France; 85. Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 86. Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany
A pragmatic randomized controlled trial to improve inhaler technique using mHealth
AuthorsAnna Vanoverschelde; Paulien van der Wel; Barbara Putman; Lies Lahousse
Affiliations1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium; 2. Department of Medicine and Department of Environmental Medicine, New York University School of Medicine, New York, USA
Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes
AuthorsGador Bogas; Cristobalina Mayorga; Ángela Martín-Serrano; Rubén Fernández-Santamaría; Isabel M. Jiménez-Sánchez; Adriana Ariza; Esther Barrionuevo; Teresa Posadas; María Salas; Tahía Diana Fernández; María José Torres; María Isabel Montañez
Affiliations1. Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain; 2. Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain; 3. Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain; 4. Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga, Málaga, Spain; 5. Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain
Highlights and recent developments in allergic diseases in EAACI journals (2019)
AuthorsJ. Bousquet; C. E. Grattan; C. A. Akdis; P. A. Eigenmann; K. Hoffmann-Sommergruber; I. Agache; M. Jutel
Affiliations1. MACVIA-France, Montpellier, France; 2. CHRU Arnaud de Villeneuve, Montpellier Cedex 5, France; 3. St John’s Institute of Dermatology, Guy’s Hospital, London, UK; 4. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland; 5. Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland; 6. Depart of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria; 7. Transylvania University Brasov, Brasov, Romania; 8. Department of Clinical Immunology, Wrocław Medical University, Wrocław, Poland; 9. ALL-MED Medical Research Institute, Wrocław, Poland
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
AuthorsJean Bousquet; Jean-Paul Cristol; Wienczyslawa Czarlewski; Josep M. Anto; Adrian Martineau; Tari Haahtela; Susana C. Fonseca; Guido Iaccarino; Hubert Blain; Alessandro Fiocchi; G. Walter Canonica; Joao A. Fonseca; Alain Vidal; Hak-Jong Choi; Hyun Ju Kim; Vincent Le Moing; Jacques Reynes; Aziz Sheikh; Cezmi A. Akdis; Torsten Zuberbier
Affiliations1. Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany; 2. University Hospital Montpellier, Montpellier, France; 3. MACVIA-France, Montpellier, France; 4. Laboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU, Montpellier, France; 5. Medical Consulting Czarlewski, Levallois, France; 6. MASK-Air, Montpellier, France; 7. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 8. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 9. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 10. ISGlobAL, Barcelona, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; 11. Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; 12. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 13. GreenUPorto - Sustainable Agrifood Production Research Centre, DGAOT, Faculty of Sciences, University of Porto, Vila do Conde, Portugal; 14. Department of Advanced Biomedical Sciences, Federico II University, Napoli, Italy; 15. Department of Geriatrics, Montpellier University Hospital, Montpellier, France; 16. Division of Allergy, Department of Pediatric Medicine, The Bambino Gesu Children’s Research Hospital Holy See, Rome, Italy; 17. Personalized Medicine Asthma and Allergy Clinic-Humanitas University & Research Hospital, IRCCS, Milano, Italy; 18. CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida,, Porto, Portugal; 19. World Business Council for Sustainable Development (WBCSD) Maison de la Paix, Geneva, Switzerland; 20. AgroParisTech-Paris Institute of Technology for Life, Food and Environmental Sciences, Paris, France; 21. Microbiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea; 22. SME Service Department, Strategy and Planning Division, World Institute of Kimchi, Gwangju, Korea; 23. Maladies Infectieuses et Tropicales, CHU, Montpellier, France; 24. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 25. Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut
AuthorsAnna M. Ehlers; Stefanie Rohwer; Henny G. Otten; Bettina Brix; Thuy-My Le; Waltraud Suer; André C. Knulst
Affiliations1. Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; 2. Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; 3. Euroimmun AG, Lübeck, Germany
Hereditary angioedema caused by a premature stop codon mutation in the SERPING1 gene
AuthorsYing-Yang Xu; Jian-Qing Gu; Yu-Xiang Zhi
Affiliations1. Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
